FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $115,000 | +228.6% | 37,653 | +159.7% | 0.00% | – |
| Q2 2019 | $35,000 | -85.9% | 14,500 | -78.0% | 0.00% | – |
| Q1 2019 | $248,000 | +90.8% | 66,000 | +81.9% | 0.00% | – |
| Q4 2018 | $130,000 | -96.4% | 36,280 | -94.2% | 0.00% | -100.0% |
| Q3 2018 | $3,582,000 | +42.5% | 625,112 | +24.6% | 0.00% | 0.0% |
| Q2 2018 | $2,513,000 | +3206.6% | 501,621 | +3281.1% | 0.00% | – |
| Q1 2018 | $76,000 | -83.2% | 14,836 | -83.8% | 0.00% | – |
| Q1 2017 | $452,000 | +141.7% | 91,306 | +441.5% | 0.00% | – |
| Q4 2016 | $187,000 | – | 16,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |